MedTrace Logo

Intervention to Improve Engagement in Care Among Newly Diagnosed HIV-positive Men

NCT01559805 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 202

Last updated 2022-01-10

No results posted yet for this study

Summary

The study involves delivering one of two interventions - either Promoting Action Towards Health (PATH) or Personalized Cognitive Counseling (PCC) - to 440 men who have sex with men (MSM) who have recently been diagnosed with HIV and assessing whether participants who received PATH achieve greater suppression of HIV viral load, demonstrate greater uptake of care and adherence to treatment, and engage in less sexual HIV transmission risk behavior than participants who received PCC.

* PATH consists of two preliminary sessions plus "booster" sessions after 1, 3, and 6 months.
* Personalized Cognitive Counseling consists of one session.

Participants will complete assessments before participating in their intervention (i.e., at "baseline") and at 3, 6, 9, and 12 month follow-up points. Participants' viral loads will be measured at approximately 6 and 12 months following baseline.

Conditions

  • HIV
  • Patient Compliance

Interventions

BEHAVIORAL

Positive Choices

A two-session, individually-focused intervention focusing on engagement in care, disclosure decision-making, and sexual risk reduction, with booster sessions after 1, 3 and 6 months.

BEHAVIORAL

Personalized Cognitive Counseling

A one-session, individually-focused risk reduction intervention for MSM that has been selected by the CDC as a DEBI.

Sponsors & Collaborators

Principal Investigators

  • Patrick A Wilson, PhD · Columbia University

  • Nathan B Hansen, PhD · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2017-11-06
Completion
2021-12-14

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01559805 on ClinicalTrials.gov